Revvity Acquires ACD/Labs to Expand Revvity Signals Scientific Software Capabilities

November 10, 2025

Revvity, Inc. has entered into a definitive agreement to acquire ACD/Labs, a provider of scientific software for analytical characterization and molecular design. The deal is expected to close in late Q4 2025 and will expand Revvity Signals by unifying analytical data with actionable scientific insights across the end-to-end scientific workflow.

Buyers
Revvity, Inc.
Targets
ACD/Labs
Industry
Cloud & SaaS
Location
Canada
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.